1. Home
  2. VTYX vs NEOV Comparison

VTYX vs NEOV Comparison

Compare VTYX & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTYX
  • NEOV
  • Stock Information
  • Founded
  • VTYX 2018
  • NEOV 2018
  • Country
  • VTYX United States
  • NEOV United States
  • Employees
  • VTYX N/A
  • NEOV N/A
  • Industry
  • VTYX Medicinal Chemicals and Botanical Products
  • NEOV Industrial Machinery/Components
  • Sector
  • VTYX Health Care
  • NEOV Miscellaneous
  • Exchange
  • VTYX Nasdaq
  • NEOV Nasdaq
  • Market Cap
  • VTYX 154.9M
  • NEOV 153.9M
  • IPO Year
  • VTYX 2021
  • NEOV N/A
  • Fundamental
  • Price
  • VTYX $3.65
  • NEOV $5.51
  • Analyst Decision
  • VTYX Buy
  • NEOV Hold
  • Analyst Count
  • VTYX 3
  • NEOV 1
  • Target Price
  • VTYX $10.00
  • NEOV N/A
  • AVG Volume (30 Days)
  • VTYX 1.5M
  • NEOV 361.5K
  • Earning Date
  • VTYX 11-06-2025
  • NEOV 11-07-2025
  • Dividend Yield
  • VTYX N/A
  • NEOV N/A
  • EPS Growth
  • VTYX N/A
  • NEOV N/A
  • EPS
  • VTYX N/A
  • NEOV N/A
  • Revenue
  • VTYX N/A
  • NEOV $8,426,835.00
  • Revenue This Year
  • VTYX N/A
  • NEOV $91.25
  • Revenue Next Year
  • VTYX N/A
  • NEOV $30.38
  • P/E Ratio
  • VTYX N/A
  • NEOV N/A
  • Revenue Growth
  • VTYX N/A
  • NEOV 218.59
  • 52 Week Low
  • VTYX $0.78
  • NEOV $1.80
  • 52 Week High
  • VTYX $4.05
  • NEOV $6.19
  • Technical
  • Relative Strength Index (RSI)
  • VTYX 62.22
  • NEOV 57.81
  • Support Level
  • VTYX $3.48
  • NEOV $5.30
  • Resistance Level
  • VTYX $4.04
  • NEOV $6.19
  • Average True Range (ATR)
  • VTYX 0.30
  • NEOV 0.50
  • MACD
  • VTYX 0.04
  • NEOV 0.02
  • Stochastic Oscillator
  • VTYX 72.93
  • NEOV 66.43

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

About NEOV NeoVolta Inc.

NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.

Share on Social Networks: